Actively Recruiting
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Led by University of California, Los Angeles · Updated on 2026-01-30
250
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.
CONDITIONS
Official Title
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients admitted to the Surgical, Cardiothoracic or Neuro ICU
- ICU stay longer than 24 hours
You will not qualify if you...
- Patients with muscular or mitochondrial diseases affecting muscle quality or mass
- Preexisting paralysis
- Absence of lower limbs
- Ongoing discussions about goals of care
- Transfers from a skilled nursing facility
- Children under the age of 18
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
J
Jennifer Scovotti, MA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here